Alprostadil in Maculopathy Study (AIMS)
Condition(s):Macular DegenerationLast Updated:October 27, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Macular DegenerationLast Updated:October 27, 2014Terminated
Condition(s):Subretinal Hemorrhage and Exudative MaculopathyLast Updated:January 4, 2011Unknown status
Condition(s):Epiretinal Membrane; Macular PuckerLast Updated:October 31, 2017Completed
Condition(s):Branch Retinal Vein OcclusionLast Updated:December 4, 2012Completed
Condition(s):Central Serous ChorioretinopathyLast Updated:May 16, 2018Completed
Condition(s):Cystoid Macular Edema, Postoperative; Diabetes MellitusLast Updated:January 5, 2016Completed
Condition(s):Central Retinal Vein OcclusionLast Updated:July 8, 2020Completed
Condition(s):Rhegmatogenous Retinal DetachmentLast Updated:May 16, 2011Completed
Condition(s):Age-Related Macular DegenerationLast Updated:January 3, 2024Recruiting
Condition(s):Macular EdemaLast Updated:October 16, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.